BrainsWay 2021 logo.jpg
NeuroMed TMS Centers, LLC Partners With Brainsway to Provide Deep Transcranial Magnetic Stimulation (Deep TMS) to Those Suffering From Depression
25 nov. 2015 08h00 HE | BrainsWay Ltd.
PHILADELPHIA, Nov. 25, 2015 (GLOBE NEWSWIRE) -- Brainsway, a leading developer of a breakthrough technology for the treatment of brain disorders, today announced a partnership with NeuroMed TMS...
Telemynd.png
MYnd Analytics to be Featured on Varney & Co.
12 nov. 2015 15h45 HE | MYnd Analytics, Inc.
ALISO VIEJO, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (OTCQB:CNSO)  MYnd Analytics CEO, George Carpenter, is scheduled to appear live in-studio on the Friday, November...
Caregivers Have Higher Levels of Depression Than Non-Caregivers
11 nov. 2015 03h05 HE | KantarHealth
NEW YORK, Nov. 11, 2015 (GLOBE NEWSWIRE) -- Caregivers of adult relatives have higher levels of depression than non-caregivers, with caregivers in China and Italy having the most severe depression...
Telemynd.png
CNS Response is Finalist for Innovations in Healthcare Award
02 sept. 2015 09h00 HE | MYnd Analytics, Inc.
ALISO VIEJO, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) -- CNS Response, Inc. (OTCQB:CNSO) CNS Response has been named a Finalist for the Innovations in Healthcaresm Award by the Adaptive Business...
New Study Shows Homocysteine Reduction Directly Correlates With Higher Remission Rates in Depression
29 juil. 2015 18h03 HE | JayMac Pharmaceuticals
SUNSET, La., July 29, 2015 (GLOBE NEWSWIRE) -- It has been common knowledge in the medical community that administering B9 (folates), B12, and B6 will lower homocysteine levels in the body. However,...
New Study Proves Homocysteine Theory of Depression: Lower Homocysteine, Achieve Higher Remission Rates in Major Depressive Disorder
29 juil. 2015 18h02 HE | JayMac Pharmaceuticals (EnLyte)
SUNSET, La., July 29, 2015 (GLOBE NEWSWIRE) -- Major Depressive Disorder (MDD) affects up to 25% of people and the literature is clear that previous standards of treatment fall short: only 30% of...
Breakthrough Depression Study Shows 42% Remission Rate With EnLyte
29 juil. 2015 18h00 HE | JayMac Pharmaceuticals
SUNSET, La., July 29, 2015 (GLOBE NEWSWIRE) -- A new study shows patients with Major Depressive Disorder and the MTHFR enzyme polymorphism significantly benefit from reduced B vitamin therapy,...
EnLyte logo
Makers of EnLyte Proud To Support Annual Meeting of the American Association of Nurse Practitioners
08 juin 2015 11h32 HE | JayMac Pharmaceuticals (EnLyte)
SUNSET, La., June 8, 2015 (GLOBE NEWSWIRE) -- The national meeting of the American Association of Nurse Practitioners begins June 9th in New Orleans, bringing together over 5,000 nurse practitioners...
Hopewell Develops Ne
Hopewell Develops New Assessment Tool; Indicates Whether Therapeutic Farm is Best for Individuals
05 mai 2015 13h28 HE | Hopewell
Mesopotamia, OH, May 5, 2015 (GLOBE NEWSWIRE) -- The first step in getting treatment for mental illness is attaining a correct assessment and diagnosis.  This can be difficult as mental health...
Makers of EnLyte Honor Autism Awareness Month
16 avr. 2015 18h02 HE | JayMac Pharmaceuticals (EnLyte)
SUNSET, La., April 16, 2015 (GLOBE NEWSWIRE) -- The rate of autism is now up to 1 in 68 children, according to the CDC. How does homocysteine have a significant impact on this...